Transforming Precision Oncology with QuantideX®: Sensitivity Meets Scalability
QuantideX advances precision oncology by delivering molecular solutions that support confident decision-making in both clinical and research settings. The comprehensive portfolio—spanning medical devices and research‑use‑only products—provides highly sensitive and accurate results through innovative, multiplexed workflows.
Purpose-built for laboratory efficiency, the QuantideX suite features intuitive software that streamlines data reporting and automates complex calculations to reduce errors and maximize throughput. Ready‑to‑use kits with pre‑mixed, quality‑controlled reagents help minimize hands‑on time and operational costs without compromising performance—enabling reliable results.
QuantideX qPCR ESR1 exoMutation Kit
The Quantidex qPCR ESR1 exoMutation Kit is the first multi-analyte liquid biopsy assay tailored for detecting ESR1 mutations. Designed to provide highly sensitive detection in 11 of the most prevalent ESR1 variants in plasma, the kit offers a novel approach to achieving more meaningful breast cancer insights.
The QuantideX® HemOnc Portfolio Delivers Sensitive Results within a Single, Streamlined, Multiplex Workflow
QuantideX qPCR BCR-ABL IS Kit
The Quantidex qPCR BCR-ABL IS Kit provides labs with a robust and reliable method for monitoring patients with CML.
Learn More About the BCR-ABL IS Kit »
QuantideX qPCR BCR-ABL minor Kit
The Quantidex qPCR BCR-ABL minor Kit has a workflow similar to the IS Kit, this assay allows labs to easily implement both assays to provide a more streamlined workflow.
Learn More About the BCR-ABL minor Kit »
QuantideX qPCR PML-RARA Kit
The QuantideX® qPCR PML-RARA Kit offers sensitive and scalable detection of three PML-RARA aberrant fusions in a single, multiplex RT-qPCR reaction, with results in approximately four hours.
Learn More About the PML-RARA Kit »
QuantideX qPCR JAK2 Kit
The QuantideX® qPCR JAK2 Kit delivers highly sensitive and quantitative detection of the JAK2 V617F mutation relative to an endogenous control sequence.
